Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Snipr Biome Aps currently has 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are split between 2 distinct art units, suggesting that the company's technology touches on different specialized areas within the broader biotech field. The prosecution is also divided among 3 distinct examiners, providing three different points of contact at the patent office. This distribution requires the company to manage multiple examiner relationships while navigating the specific standards of the different departments.
Examiner RAHMAN, MASUDUR is the busiest examiner, managing 1 pending office action. This indicates an even distribution of the workload, as no single official handles more than one case. Practitioners must be prepared to address the individual styles of the different examiners while ensuring that the overall strategy remains cohesive across the Biotechnology & Pharmaceuticals sector. The involvement of 2 distinct art units suggests that the company's innovations may have diverse applications that necessitate review by different specialized groups.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (25%) |
| Double-patenting + other | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAHMAN, MASUDUR | 1 | 72.7% | +31.7% |
| GANGLE, BRIAN J | 1 | 76.7% | +14.7% |
| VIVLEMORE, TRACY ANN | 1 | 73.0% | +6.6% |
| CHEN, STACY BROWN | 1 | 66.1% | +40.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18763680 | TRANSMISSIBLE ELEMENTS COMPRISING PATHWAY MODIFICATION SYSTEMS AND EXOGENOUS NUCLEIC ACIDS FOR THE PRODUCTION OF MOLECULES OF INTEREST | RAHMAN, MASUDUR | — |
| 18314755 | PHAGE AND TRANSDUCTION PARTICLES | VIVLEMORE, TRACY ANN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18763680 | TRANSMISSIBLE ELEMENTS COMPRISING PATHWAY MODIFICATION SYSTEMS AND EXOGENOUS NUCLEIC ACIDS FOR THE PRODUCTION OF MOLECULES OF INTEREST | RAHMAN, MASUDUR | — |
| 18294101 | MICROBIOTA ENGINEERING | GANGLE, BRIAN J | — |
| 18027847 | SYNTHETIC VIRUSES | CHEN, STACY BROWN | — |
| Art Unit | Apps |
|---|---|
| 1645 | 1 |
| 1638 | 1 |
| 1672 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18763680 | TRANSMISSIBLE ELEMENTS COMPRISING PATHWAY MODIFICATION SYSTEMS AND EXOGENOUS NUCLEIC ACIDS FOR THE PRODUCTION OF MOLECULES OF INTEREST | RAHMAN, MASUDUR | — | §102§112 | Non-Final OA | — | Pending | Jul 03, 2024 |
| 18294101 | MICROBIOTA ENGINEERING | GANGLE, BRIAN J | 1645 | §112 | Non-Final OA | — | Pending | Jan 31, 2024 |
| 18314755 | PHAGE AND TRANSDUCTION PARTICLES | VIVLEMORE, TRACY ANN | 1638 | §103§112 | Final Rejection | — | Pending | May 09, 2023 |
| 18027847 | SYNTHETIC VIRUSES | CHEN, STACY BROWN | 1672 | §102§112DPOther | Final Rejection | — | Pending | Mar 22, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial